HOLMAN SUSAN HARTJES 4
4 · UROPLASTY INC · Filed Jun 2, 2011
Insider Transaction Report
Form 4
Transactions
- Sale
common stock
2011-05-31$8.08/sh−6,000$48,500→ 315,759 total - Exercise/Conversion
common stock
2011-06-02$4.31/sh+10,000$43,100→ 314,659 total - Exercise/Conversion
non-qualified stock options
2011-06-02−10,000→ 0 totalExercise: $4.31From: 2007-07-03Exp: 2012-07-02→ common stock (10,000 underlying)
Holdings
- 100,000
non-qualified stock options
Exercise: $5.19From: 2006-02-02Exp: 2015-01-01→ common stock (100,000 underlying) - 10,000
non-qualified stock options
Exercise: $3.15From: 2008-06-24Exp: 2013-06-23→ common stock (10,000 underlying) - 12,500
non-qualified stock options
Exercise: $2.65From: 2008-02-02Exp: 2014-02-01→ common stock (12,500 underlying) - 40,000
non-qualified stock options
Exercise: $0.85From: 2009-06-05Exp: 2014-06-04→ common stock (40,000 underlying) - 6,525
non-qualified stock options
Exercise: $4.94From: 2011-06-08Exp: 2017-06-07→ common stock (6,525 underlying)
Footnotes (6)
- [F1]Includes 5,100 shares of restricted stock subject to risk of forfeiture that lapses with respect to one fourth of such shares on each of the first, second, third and fourth anniversaries of the grant date (June 8, 2010).
- [F2]Fully vested.
- [F3]Becomes exercisable with respect to one-third of the shares on such date, and an additional, cumulative one-third on the first and second anniversary of such date.
- [F4]Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.121 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5).
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.082 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6).